Compile Data Set for Download or QSAR
maximum 50k data
Found 5 of ki for monomerid = 103367
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  0.400nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi: >3.00E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  3.20E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  4.00E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  4.50E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent